RADIOFREQUENCY VS. CRYOABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: A COMPREHENSIVE COMPARATIVE STUDY
Global Journal of Medical and Pharmaceutical Sciences · 2022
DOI: 10.55640/gjmps-abcd01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Medical and Pharmaceutical Sciences, 2022. Verfasst von Ahmed Nawar.
Abstract (Originalsprache)
Paroxysmal atrial fibrillation (PAF) presents a significant challenge in clinical management due to its recurrent nature and associated risks of stroke and other complications. Radiofrequency ablation (RFA) and cryoablation have emerged as effective strategies for restoring sinus rhythm in patients with PAF. This comprehensive comparative study aims to evaluate the efficacy, safety, and long-term outcomes of RFA versus cryoablation in the treatment of PAF. A thorough analysis of available literature, clinical trials, and observational studies was conducted to assess the procedural success rates, recurrence rates, complication rates, and quality of life outcomes associated with each ablation modality. Factors such as procedural duration, cost-effectiveness, and patient preferences were also considered. The findings of this study provide valuable insights into the optimal selection of ablation techniques for patients with PAF, guiding clinicians in personalized treatment decisions and improving overall patient care.
Zitieren
APA
Nawar, A. (2022). RADIOFREQUENCY VS. CRYOABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: A COMPREHENSIVE COMPARATIVE STUDY. Global Journal of Medical and Pharmaceutical Sciences. https://doi.org/10.55640/gjmps-abcd01
Vancouver
Nawar A. RADIOFREQUENCY VS. CRYOABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: A COMPREHENSIVE COMPARATIVE STUDY. Global Journal of Medical and Pharmaceutical Sciences. 2022. doi:10.55640/gjmps-abcd01
BibTeX
@article{Nawar2022,
author = {Nawar, Ahmed},
title = {RADIOFREQUENCY VS. CRYOABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: A COMPREHENSIVE COMPARATIVE STUDY},
journal = {Global Journal of Medical and Pharmaceutical Sciences},
year = {2022},
doi = {10.55640/gjmps-abcd01}
}
EUVIMED